Search Results - "Blissett, Rob"

Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment by Fagiuoli, Stefano, Ruggeri, Matteo, Aragao, Filipa, Blissett, Rob

“…The current paradigm (CP) of hepatitis C virus (HCV) diagnosis and treatment in Italy's National Health Service system has numerous steps. The European…”
Get full text

Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective by Blissett, Deirdre B., Steier, Joerg S., Karagama, Yakubu G., Blissett, Rob S.

“…Background Hypoglossal nerve stimulation (HNS) with Inspire is a novel treatment indicated for moderate or severe obstructive sleep apnoea/hypopnoea syndrome…”
Get full text

Minimally Invasive Sacroiliac Joint Fusion with Triangular Titanium Implants: Cost-Utility Analysis from NHS Perspective by Blissett, Deirdre B., Blissett, Rob S., Ede, Matthew P. Newton, Stott, Philip M., Cher, Daniel J., Reckling, W. Carlton

“…Objective The aim was to identify the cost-effectiveness of minimally invasive sacroiliac joint fusion (MI SIJF) surgery with titanium triangular implants for…”
Get full text

Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States by Dieterich, Douglas T., Reau, Nancy S., Ahmed, Aijaz, Blissett, Rob, Igloi-Nagy, Adam, Yehoshua, Alon

Get full text

FRI-141 - Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States by Dieterich, Douglas T., Reau, Nancy S., Ahmed, Aijaz, Blissett, Rob, Igloi-Nagy, Adam, Yehoshua, Alon

Get full text

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered by Younossi, Zobair, Blissett, Deidre, Blissett, Rob, Henry, Linda, Younossi, Youssef, Beckerman, Rachel, Hunt, Sharon

“…Background & Aims Hepatitis C virus (HCV) treatment with all oral direct acting antiviral agents (DAA's) achieve sustained virologic response (SVR) rates of…”
Get full text

The value of increased HCV testing and treatment strategies in Spain to achieve elimination goals by Calleja Panero, José Luis, Espin, Jaime, Kaushik, Ankita, Guerra, Manuel Hernández, Blissett, Rob, Igloi-Nagy, Adam, Yehoshua, Alon

Get full text

Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea by Kim, Do Young, Wong, Gabriel, Lee, Janet, Kim, Myung Hwa, Smith, Nathaniel, Blissett, Rob, Kim, Hyung Joon

“…Given a hepatitis C virus (HCV) elimination goal by 2030, World Health Organization (WHO) guidelines recommend scaling up HCV screening and treatment with…”
Get full text

The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals by Calleja, Jose Luis, Espin, Jaime, Kaushik, Ankita, Hernandez-Guerra, Manuel, Blissett, Rob, Yehoshua, Alon, Igloi-Nagy, Adam

“…Background In 2015, Spain launched a national eradication strategy for hepatitis C virus (HCV), resulting in the highest treatment rate in Europe and…”
Get full text

An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States by Oluwole, Olalekan O, Patel, Anik R, Vadgama, Sachin, Smith, Nathaniel J, Blissett, Rob, Feng, Chaoling, Dickinson, Michael, Johnston, Patrick B, Perales, Miguel-Angel

“…This economic evaluation of axicabtagene ciloleucel (axi-cel) versus previous standard of care (SOC; salvage chemotherapy followed by high-dose therapy with…”
Get more information

In an era of highly effective treatment, hepatitis C screening ofￂ the United States general population should be considered by Younossi, Zobair, Blissett, Deidre, Blissett, Rob, Henry, Linda, Younossi, Youssef, Beckerman, Rachel, Hunt, Sharon

“…Background & Aims Hepatitis C virus (HCV) treatment with all oral direct acting antiviral agents (DAA's) achieve sustained virologic response (SVR) rates of…”
Get full text

Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system by De la Cuadra-Grande, Alberto, Rioja-Zuazu, Jorge, Domínguez-Esteban, Mario, Torres, Esperanza, Blissett, Rob, Woodward, Emily, Oyagüez, Itziar, Fernández-Arjona, Manuel

“…Several surgical treatments are available for managing lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH). Water vapor thermal…”
Get more information

The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial by Perales, Miguel-Angel, Kuruvilla, John, Snider, Julia Thornton, Vadgama, Sachin, Blissett, Rob, El-Moustaid, Fadoua, Smith, Nathaniel J., Patel, Anik R., Johnston, Patrick B.

“…Axicabtagene ciloleucel (axi-cel) was found to have superior clinical outcomes compared to standard of care (SOC; salvage chemoimmunotherapy, followed by…”
Get full text